PS Ratio: 21.65

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 21.65 is 15% below its estimated 3-year average of 25.61, near the low end of its estimated 3-year range (11.05–530.16).

As of 2026-10-06T17:37:06.095Z. 1.82% above its estimated 12-month average of 21.26.

KRYS PS Ratio Metrics

P/S vs. estimated history

At 21.65, P/S is at an extreme level, where the multiple carries little signal — higher than 25% of readings in its estimated 8-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Krystal Biotech, Inc. (KRYS)?

The P/S ratio for KRYS stock is 21.65.

Is Krystal Biotech, Inc.'s P/S ratio high or low?

The P/S ratio of 21.65 is 15% below its estimated 3-year average of 25.61, near the low end of its estimated 3-year range (11.05–530.16).

What is the estimated TTM average P/S ratio for Krystal Biotech, Inc. (KRYS)?

The estimated TTM average P/S ratio for KRYS stock is 21.26.

What is the estimated 3Y average P/S ratio for Krystal Biotech, Inc. (KRYS)?

The estimated 3Y average P/S ratio for KRYS stock is 25.61.

What is the estimated 5Y average P/S ratio for Krystal Biotech, Inc. (KRYS)?

The estimated 5Y average P/S ratio for KRYS stock is 25.61.

Showing the most recent 260 of 1,297 data points. The chart above shows the full history.

Related Metrics